Mike Dineen is an accomplished healthcare executive with extensive experience in the medical device industry. Currently serving as President, CEO, and Co-founder of Tioga Cardiovascular since April 2019, Mike has been instrumental in developing transcatheter mitral and tricuspid valve systems. Previous roles include Board Observer at NuVera Medical and Executive In Residence at Shifamed, contributing to the creation and management of several successful medical technology companies. Mike's leadership also spans positions at Terumo Medical Corporation and Abbott, where significant milestones, such as regulatory approvals and product launches, were achieved. With a foundational background as President & CEO of Kalila Medical and extensive experience in business development, marketing, and regulatory affairs at established firms like Covidien and Concentric Medical, Mike holds an MBA and a BS in Biology from Santa Clara University.